智通财经APP讯，中国太平(00966)3月25日晚间披露2025年全年业绩。数据显示，中国太平2025年实现 股东应占溢利 270.59 亿港元，较2024年同期大幅增220.9%，盈利水平刷新近年纪录。股东回报方面， 公司拟派发2025年末期股息每股1.23港元，较去年增长251.4%，分红占比达16.3%，派息力度超市场预 期。 ...

EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 中國太平保險控股有限公司 | | 股份代號 | 00966 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年12月31日止年度末期股息 | | 公告日期 | 2026年3月25日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年12月31日 | | 宣派股息 | 每 股 1.23 HKD | | 股東批准日期 | 有待公佈 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | 每 股 1.23 HKD | | 匯率 | 1 HKD : 1 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不 發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 本公告所載有關截至 2025 年及 2024 年 12 月 31 日止年度的財務資料並不構成本集團該等年度的法定年度綜合財 務報表，但乃源自該等財務報表。根據《公司條例》第 436 條須就該等法定財務報表披露的其他資料如下： 本集團已根據《公司條例》第 662(3) 條及附表 6 第 3 部向公司註冊處處長提交截至 2024 年 12 月 31 日止年度的財 務報表，並將適時提交截至 2025 年 12 月 31 日止年度的財務報表。 本集團的核數師已就該兩年度的綜合財務報表提交報告。核數師報告並無保留意見，亦無提述核數師在不就 該等報告作保留的情況下以強調的方式促請有關人士注意的任何事項，也沒有載列根據《公司條例》第 406(2) 、 407(2) 或 (3) 條作出的陳述。 （於香港註冊成立之有限公司） （股份代號：966） 公 告 截至 2025 年 12 月 31 日止年度業績 中國太平保險控股 ...

China Taiping Insurance Holdings Company Limited 2025 Annual Results Presentation March 2026 Forward-Looking Statements and Declarations This presentation and the ensuing discussions may contain certain forward-looking statements regarding the financial condition, results of operations and businesses of China Taiping Insurance Holdings Company Limited. Such forward-looking statements represent China Taiping Insurance Holdings Company Limited's expectations or beliefs about future events, including known or ...

Summary of China Taiping's Conference Call Company Overview - **Company**: China Taiping Insurance Holdings Company Limited - **Industry**: Insurance Key Points Financial Performance - **2025 Earnings Forecast**: Expected net profit growth of 215%-225%, driven by new accounting standards and a recovering capital market [2][12] - **Revenue Trends**: Revenue decreased from 268 billion CNY in 2022 to 135.2 billion CNY in 2023 due to new accounting standards, but is projected to recover to 168.8 billion CNY in 2024 and 53.8 billion CNY in H1 2025 [4][12] - **Net Profit Fluctuations**: Significant increase in net profit by 95% in 2023 due to accounting changes, with continued growth in H1 2025 [4][5] Business Structure and Growth - **Core Business**: Life insurance remains the core, contributing 84.3% of total premiums and 90.1% of net profit in H1 2025 [5] - **New Business Value (NBV)**: NBV increased by 21% in 2024 and 22.9% in H1 2025, benefiting from product structure optimization and the "reporting and operation integration" policy [5][12] - **Distribution Channels**: Significant growth in the bancassurance channel, with NBV contribution rising from 1.9% in 2019 to 31.1% in H1 2025 [2][9] Strategic Initiatives - **Transformation in Participating Insurance**: Leading transformation strategy in participating insurance, with new single premium growth nearing 120% in H1 2025 [6] - **Agent Channel Adjustments**: Agent numbers decreased from 510,000 in 2018 to 225,000 in H1 2025, with a focus on quality over quantity [7][8] - **Investment Strategy**: Asset allocation heavily favors fixed income, with bonds comprising 76.5% of the portfolio, indicating potential for performance improvement [2][11] Market Position and Valuation - **Valuation Metrics**: Current P/EV ratio is 0.34, significantly lower than industry peers, indicating attractive valuation [2][13] - **Historical Stock Performance**: Historically, stock price has shown higher elasticity during bull markets compared to the Hang Seng Index, suggesting potential for recovery [13] Future Outlook - **Projected Growth**: Anticipated premium income growth of 1.5% to 5.5% from 2025 to 2027, with new single premium growth expected to reach 12.1% [12] - **Dividend Potential**: Despite fluctuations, the company has a solid foundation for increasing dividend levels in the future [5][12] Risk Factors - **Market Sensitivity**: The company’s performance is sensitive to macroeconomic conditions and geopolitical factors, which could impact the insurance sector [13] Conclusion China Taiping is positioned for significant growth driven by strategic transformations in its insurance offerings and distribution channels, alongside a favorable valuation compared to peers. The company’s focus on fixed income investments and a strong foundation in life insurance provides a robust platform for future profitability and shareholder returns.

Core Viewpoint - The Hong Kong stock market saw a collective rise in insurance stocks, driven by a recent meeting of the financial regulatory authority emphasizing the enhancement of financial services for the real economy and the development of various insurance products [1][3]. Group 1: Market Performance - China Pacific Insurance rose over 4%, while New China Life and Yunfeng Financial increased by over 3%. Other companies such as China People's Insurance Group, China Taiping, ZhongAn Online, China Reinsurance, Ping An, and China Life all saw gains exceeding 2% [1][3]. - The MACD golden cross signal formation indicates a positive trend for these stocks [3]. Group 2: Company Specifics - **China Pacific Insurance (00966)**: Increased by 4.29%, latest price at 22.360, market cap of 80.362 billion, year-to-date change of 19.64% [2][4]. - **New China Life (01336)**: Increased by 3.78%, latest price at 53.600, market cap of 167.208 billion, year-to-date change of -1.38% [2][4]. - **Yunfeng Financial (00376)**: Increased by 3.09%, latest price at 3.340, market cap of 13.558 billion, year-to-date change of 5.70% [2][4]. - **China People's Insurance Group (01339)**: Increased by 2.92%, latest price at 6.350, market cap of 280.822 billion, year-to-date change of -5.93% [2][4]. - **China Taiping (02601)**: Increased by 2.53%, latest price at 34.900, market cap of 335.75 billion, year-to-date change of -0.85% [2][4]. - **ZhongAn Online (06060)**: Increased by 2.38%, latest price at 14.630, market cap of 24.649 billion, year-to-date change of -9.07% [2][4]. - **China Reinsurance (01508)**: Increased by 2.96%, latest price at 1.740, market cap of 73.915 billion, year-to-date change of 3.57% [2][4]. - **Ping An (02318)**: Increased by 2.33%, latest price at 63.700, market cap of 1.15 trillion, year-to-date change of -2.23% [2][4]. - **China Life (02628)**: Increased by 2.18%, latest price at 29.060, market cap of 821.372 billion, year-to-date change of 6.14% [2][4].

Core Conclusion - China Taiping, a century-old comprehensive insurance group controlled by the Ministry of Finance, is leading the industry in the transformation of dividend insurance and optimizing its investment side, providing growth potential and value. The company is rated "Buy" for the first time due to its strategic determination backed by state-owned assets and its full-license collaborative advantages [1]. Group 1: Business Overview - The company is a state-owned comprehensive insurance group controlled by the Ministry of Finance, with a clear division of responsibilities within its management team. The life insurance segment is the cornerstone of its business, expected to account for 90.1% of segment profits by the first half of 2025, while property and casualty insurance and reinsurance businesses are operating steadily [1]. - By the first half of 2025, the total investment assets are projected to reach HKD 1.68 trillion, with fixed-income assets serving as the foundation and significant room for equity investments [1]. Group 2: Competitive Advantages - The company is leading in the transformation of dividend insurance, with a liability structure that continues to optimize. In the first half of 2025, the growth rate of dividend insurance is nearly 120%, with new individual and bancassurance long-term policies accounting for 97.5% and 85.8% respectively. The long-term stability of the dividend realization rate (average of 93% from 2014 to 2024) positions dividend insurance as a core tool for stabilizing net profit and net asset fluctuations, while providing a steady source of investable funds [1]. - The company adheres to a fixed-income strategy, with bond assets increasing to 76.5%, effectively mitigating market volatility. The equity position is currently low, indicating significant potential for increased investment. Historical performance shows that the company has demonstrated notable elasticity during market uptrends, and with enhanced equity research capabilities and resource allocation, investment returns are expected to see substantial growth [2]. - As a full-license insurance group, the company benefits from resource sharing and collaborative empowerment among its life, property, casualty, reinsurance, and asset management businesses. The state-controlled ownership structure provides long-term strategic stability, supporting business transformation and investment strategy optimization [2].

Investment Rating - The report assigns a "Buy" rating to China Taiping (00966.HK) for its strong growth potential and strategic advantages [6]. Core Insights - China Taiping, a century-old comprehensive insurance group controlled by the Ministry of Finance, is leading the industry in the transformation of dividend insurance and optimizing its investment side, which enhances its growth flexibility. The company's state-owned background provides strategic stability and synergy advantages across its full range of licenses, making it a valuable investment opportunity [1][6]. Summary by Relevant Sections Company Overview - China Taiping is a state-owned comprehensive insurance group with a clear management structure and defined responsibilities. The life insurance segment is the cornerstone of its business, expected to account for 90.1% of profits by the first half of 2025. The total investment assets are projected to reach HKD 1.68 trillion by 2025, with a solid foundation in fixed-income assets and significant room for equity investments [1][20]. Competitive Advantages - The company is leading in the transformation of dividend insurance, with a growth rate of nearly 120% in the first half of 2025. The proportion of new individual and bank insurance channel dividend long-term insurance policies reached 97.5% and 85.8%, respectively. The long-term stable dividend realization rate (average of 93% from 2014 to 2024) positions dividend insurance as a key tool for stabilizing net profit and net asset fluctuations [2][50]. - The asset side is focused on stability and efficiency, with bond assets increasing to 76.5%, effectively mitigating market volatility. The company has a low equity position, indicating significant potential for increasing equity investments, which could lead to substantial improvements in investment returns [2][14]. - As a fully licensed insurance group, China Taiping benefits from resource sharing and collaborative empowerment among its life, property, reinsurance, and asset management businesses. The state-controlled ownership structure provides long-term strategic stability, supporting business transformation and investment strategy optimization [2][14]. Financial Performance - The insurance service revenue is projected to reach HKD 116.1 billion in 2025, with a growth rate of 4.4%. The net profit attributable to shareholders is expected to surge to HKD 26.9 billion, reflecting a growth rate of 219.6% [4][13]. - The company's earnings per share (EPS) is forecasted to be HKD 7.50 in 2025, with a price-to-earnings (P/E) ratio of 2.86, indicating a favorable valuation compared to peers [4][13]. - The company has shown resilience in its financial performance, with a significant recovery in net profit expected in the coming years, driven by the transformation of its dividend insurance and improved investment strategies [30][41]. Market Position and Growth Drivers - The market is concerned about China Taiping's low equity position, which may limit its elasticity during equity upcycles. However, the company possesses differentiated competitive advantages, including its leading position in dividend insurance transformation and a robust asset-liability management strategy [14][15]. - The upcoming catalysts for stock price appreciation include the successful execution of its dividend insurance transformation, increased new premium and net business value (NBV), and enhanced investment research capabilities [15][16]. Valuation and Target Price - The current price-to-embedded value (PEV) ratio for China Taiping is 0.28, significantly lower than its peers. The report suggests a target PEV of 0.42, corresponding to a target price of HKD 31.8 for 2026, indicating an upside potential of approximately 48% [16].

Group 1 - The company, China Taiping (00966.HK), announced that it will hold a board meeting on March 25, 2026, to consider and approve the annual performance for the year ending December 31, 2025, for itself and its subsidiaries [1] - The board meeting will also consider the distribution of a final dividend, if any [1]

承董事會命 中國太平保險控股有限公司 公司秘書 張若晗 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承 擔任何責任。 （於香港註冊成立之有限公司） （股份代號：966） 董事會會議日期 中國太平保險控股有限公司（「本公司」）宣佈，本公司將於2026年3月25日（星期三）舉行 董事會（「董事會」）會議， 藉以（其中包括）考慮及批准本公司及其附屬公司截至2025年 12月31日止年度之全年業績，以及考慮派發末期股息（如有）。 中國香港，2026 年 3 月 9 日 於本公告日期，本公司董事會由 10 名董事組成，其中尹兆君先生、李可東先生及那豔芳女士為執行董事，胡興 國先生、周梁剛先生及馮占武先生為非執行董事，羅范椒芬女士、劉怡女士、邵善波先生及蔡洪平先生為獨立 非執行董事。 ...